More Big Biotech Mergers On the Way

May 10, 2011

May 11, 2011 | Major drugmakers need the growth potential of biotech now more than ever, says David Snow. Even though drug executives and bankers are keeping quiet on big price tag mergers and acquisitions, Snow believes that more deals like Sanofi's $20.1 billion purchase of Genzime are on they way. Reuters.